The critical regulator of apoptosis, Bcl‐2 (target of navitoclax), is overexpressed in the majority of small cell lung cancer (SCLC) tumours (Ikegaki et al, 1994). The gene discussed is BCL2; the disease is small cell lung carcinoma.